The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
The Natural History of Untreated Hyperprolactinemia: A Prospective Analysis*
Abstract
This report describes the results of a long term prospective study of 30 women with hyperprolactinemia who were not treated and who underwent yearly clinical, hormonal, and radiographic evaluation for an average of 5.2 yr (range 3-7 yr). At entry into the study 18 women had amenorrhea, 8 had oligomenorrhea, and 4 had regular menstrual periods. The initial mean serum PRL levels did not differ in women grouped according to menstrual function. Nine women (35%) had improvement in clinical symptoms. Serum PRL decreased, and menstrual periods normalized more often in those who initially had oligomenorrhea or regular menstrual periods. In most amenorrheic women serum PRL levels did not decline, and menstrual symptoms did not improve. Six of 30 women had an increase in serum PRL, 14 had no change, and 10 had a decrease, in 6 of whom serum PRL was normal at the last observation. Twenty-seven women had serial radiographic studies. Four (15%) of the 13 women with initially abnormal radiographic findings had normal studies later, 2 had tumor progression, and 7 no change. Four of 14 women who had normal radiographic studies initially developed radiographic evidence of a pituitary tumor, although the radiographic changes were minimal, and no patient developed a macroadenoma or pituitary hypofunction. Increases or decreases in serum PRL did not accurately predict changes in tumor size. Prior estrogen use and previous pregnancies did not increase the likelihood of tumor appearance or enhance tumor growth. The clinical presentation of the patient was an important factor in predicting which patients had a decline in serum PRL and resolution of symptoms. We conclude that patients with hyperprolactinemia are unlikely to have progression of their disease and may, in fact, have clinical and radiographic improvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas
March, C. M., Kletzky, O. A., Davajan, V., Teal, J. S., Weiss, M., Apuzzo, M. L. J., Marrs, R. P., & Mishell, D. R. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90553-6 · Cited by 149
Nonpuerperal galactorrhea and hyperprolactinemia
Gómez, F., Reyes, F. I., & Faiman, C. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90866-x · Cited by 129
The natural history of untreated microprolactinomas
Sisam, D. A., Sheehan, J. P., & Sheeler, L. R. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59292-9 · Cited by 116
Prolactin-Secreting Pituitary Tumors in Amenorrheic Women: A Comprehensive Study*
Schlechte, J., Sherman, B. M., Halmi, N. S., VanGilder, J. C., Chapler, F. K., Dolan, K. D., Granner, D. K., DUELLO, T. M., & Harris, C. E. (1980) · Endocrine Reviews · doi:10.1210/edrv-1-3-295 · Cited by 116
Self-citationThe Natural History of Idiopathic Hyperprolactinemia*
Martin, T. L., Kim, M., & Malarkey, W. B. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-5-855 · Cited by 113
Natural History of Microprolactinomas: Six-Year Follow-up
Weiss, M. H., Teal, J. S., Gott, P. S., Wycoff, R., Yadley, R. A., Apuzzo, M. L. J., Giannotta, S. L., Kletzky, O. A., & March, C. M. (1983) · Neurosurgery · doi:10.1227/00006123-198302000-00008 · Cited by 110
Hyperprolactinemia, Amenorrhea, and Galactorrhea: A Retrospective Assessment of Twenty-five Cases
KOPPELMAN, M. C. S., JAFFE, M. J., RIETH, K. G., CARUSO, R. C., & LORIAUX, D. L. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-1-115 · Cited by 92
Johnston, D. G., Prescott, R. W. G., Kendall‐Taylor, P., Hall, K., Crombie, A. L., Hall, R., McGregor, A. M., Watson, M. J., & Cook, D. B. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90418-7 · Cited by 87
Crosignani, P. G., Ferrari, C. I., Liuzzi, A., Benco, R., MATTEI, A. M., RAMPINI, P., Dellabonzana, D., Scarduelli, C., & SPELTA, B. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)45978-9 · Cited by 44
Spontaneous development of hyperprolactinaemia
Rjosk, H. Κ., Fahlbusch, R., & von Werder, K. (1982) · European Journal of Endocrinology · doi:10.1530/acta.0.1000333 · Cited by 37
Cited by
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844
Self-citationClinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
Casanueva, F. F., Molitch, M. E., Schlechte, J. A., Abs, R., Bonert, V., Bronstein, M. D., Brue, T., Cappabianca, P., Colao, A., Fahlbusch, R., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02562.x · Cited by 829
Self-citationAdvances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
Petersenn, S., Fleseriu, M., Casanueva, F. F., Giustina, A., Biermasz, N., Biller, B. M. K., Bronstein, M., Chanson, P., Fukuoka, H., Gadelha, M., et al. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00886-5 · Cited by 411
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
Colao, A., Di Sarno, A., Cappabianca, P., Di Somma, C., Pivonello, R., & Lombardi, G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022657 · Cited by 336
Molitch, M. E., & Russell, E. J. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-12-925 · Cited by 312
Schlechte, J. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp025334 · Cited by 258
Self-citationHyperprolactinemia and Prolactinomas
Mancini, T., Casanueva, F. F., & Giustina, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.013 · Cited by 256
Chidiac, R. M., & Aron, D. C. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70242-5 · Cited by 140
Prolactin in Human Reproduction
Molitch, M. E. (2009) · Yen & Jaffe's Reproductive Endocrinology · doi:10.1016/b978-1-4160-4907-4.00003-6 · Cited by 31
Metadata
- Authors
- SCHLECHTE, J., DOLAN, K., SHERMAN, B., CHAPLER, F., & LUCIANO, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1989-02
- Volume
- 68
- Issue
- 2
- Pages
- 412-418
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2165368949
- Cited by
- 271
- References
- 11
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.